Inovio Pharmaceuticals
INO
#10055
Rank
โ‚ฌ59.41 M
Marketcap
0,58ย โ‚ฌ
Share price
-4.84%
Change (1 day)
-54.70%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,97ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,97ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,57ย โ‚ฌ an increase over its 2024 EPS that were of -3,43ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,97ย โ‚ฌ25.64%
2025-1,57ย โ‚ฌ-54.18%
2024-3,43ย โ‚ฌ-35.14%
2023-5,28ย โ‚ฌ-56.62%
2022-12,18ย โ‚ฌ-19.54%
2021-15,13ย โ‚ฌ35.9%
2020-11,13ย โ‚ฌ-11.57%
2019-12,59ย โ‚ฌ15.24%
2018-10,93ย โ‚ฌ-2.78%
2017-11,24ย โ‚ฌ6.93%
2016-10,51ย โ‚ฌ134.88%
2015-4,47ย โ‚ฌ-29.51%
2014-6,35ย โ‚ฌ-57.34%
2013-14,88ย โ‚ฌ146.55%
2012-6,04ย โ‚ฌ20.83%
2011-5,00ย โ‚ฌ-29.41%
2010-7,08ย โ‚ฌ-48.48%
2009-13,74ย โ‚ฌ10%
2008-12,49ย โ‚ฌ11.11%
2007-11,24ย โ‚ฌ-41.3%
2006-19,15ย โ‚ฌ-66.91%
2005-57,86ย โ‚ฌ110.61%
2004-27,47ย โ‚ฌ-61.63%
2003-71,60ย โ‚ฌ186.67%
2002-24,98ย โ‚ฌ
2001N/A-100%
2000-19,98ย โ‚ฌ-62.58%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,57ย โ‚ฌ-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,09ย โ‚ฌ-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,14ย โ‚ฌ-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,43ย โ‚ฌ-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,10ย โ‚ฌ-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,37ย โ‚ฌ-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,70ย โ‚ฌ-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA